Article Versions Notes

Min S, More SV, Park J-Y, Jeon S-B, Park SY, Park E-J, Yoon S-H, Choi D-K. EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells. Molecules. 2014; 19(12):19361-19375. https://doi.org/10.3390/molecules191219361

Min, Soon, Sandeep Vasant More, Ju-Young Park, Sae-Bom Jeon, Shin Young Park, Eun-Jung Park, Sung-Hwa Yoon, and Dong-Kug Choi. 2014. "EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells" Molecules 19, no. 12: 19361-19375. https://doi.org/10.3390/molecules191219361

Min, S., More, S. V., Park, J.-Y., Jeon, S.-B., Park, S. Y., Park, E.-J., Yoon, S.-H., & Choi, D.-K. (2014). EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells. Molecules, 19(12), 19361-19375. https://doi.org/10.3390/molecules191219361